STOCK TITAN

If You Invested in Concert Pharm (CNCE)

NASDAQ
Looking for the current price? See the CNCE quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2015-11-02
$1,000 invested 5 Years Ago
$2,947
+194.7% price return 124.9% CAGR
+194.7% with dividends reinvested
Bought on Nov 1, 2021 at $2.84 split-adjusted

What $1,000 or $10,000 in CNCE Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Nov 2, 2015
$1,000 — $2,947 +195% $1,084 +8% $339 -66%
$10,000 — $29,472 +195% $10,842 +8% $3,387 -66%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2023-03-03. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for CNCE

$1,000 Investment Over Time

CNCE vs S&P 500

Year-by-Year Returns

CNCE annual performance
Year Start Price End Price Annual Return Cumulative
2015 $24.71 $18.97 -23.2% -23.2%
2016 $18.97 $10.29 -45.8% -58.4%
2017 $10.29 $25.87 +151.4% +4.7%
2018 $25.87 $12.55 -51.5% -49.2%
2019 $12.55 $9.22 -26.5% -62.7%
2020 $9.22 $12.64 +37.0% -48.8%
2021 $12.64 $3.15 -75.1% -87.3%
2022 $3.15 $5.84 +85.4% -76.4%
2023 $5.84 $8.37 +43.3% -66.1%

About Concert Pharm

NASDAQ

Current Price
$8.37
View full CNCE overview

Frequently Asked Questions

Concert Pharm investment returns

How much would $1,000 invested in Concert Pharm be worth today?

If you invested $1,000 in Concert Pharm (CNCE) 10 years ago on 2016-10-31, your investment would be worth $1,084 as of 2023-03-03, a +8.4% price return without dividends, growing at a compounded rate of 1.3% per year (CAGR).

Has Concert Pharm outperformed the S&P 500?

Over the past 10 years, CNCE returned +8.4% compared to +262.1% for the S&P 500, underperforming the benchmark by 253.7 percentage points.

What is Concert Pharm's average annual return?

The compound annual growth rate (CAGR) of CNCE’s share price over the past 10 years is 1.3%, without dividends. Individual years vary a great deal, and CNCE’s best recent full year was 2017 (+151.4%) while the worst was 2021 (-75.1%).

For informational and educational purposes only, not investment advice.